Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Enveric Biosciences Inc

ENVB
Current price
1.38 USD 0 USD (0.00%)
Last closed 1.29 USD
ISIN US29405E1091
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 299 171 USD
Yield for 12 month -90.31 %
1Y
3Y
5Y
10Y
15Y
ENVB
21.11.2021 - 28.11.2021

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida. Address: 4851 Tamiami Trail N, Naples, FL, United States, 34103

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.00 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-408 030 USD

Current Quarter

Last Quarter

Key Figures ENVB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -9 294 777 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -163.10 %
PEG Ratio
Return On Equity TTM -539.57 %
Wall Street Target Price 10.00 USD
Revenue TTM 35 405 064 USD
Book Value 2.35 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -7.30 %
Dividend Yield
Gross Profit TTM 8 150 720 USD
Earnings per share -19.04 USD
Diluted Eps TTM -19.04 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ENVB

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History ENVB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date 23.04.2008
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:15
Payout Ratio TTM
Last Split Date 29.01.2025

Stock Valuation ENVB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 23.09
Enterprise Value Revenue 1.76
Price Sales TTM 0.083
Enterprise Value EBITDA 0.29
Price Book MRQ 2.07

Financials ENVB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ENVB

For 52 weeks

1.01 USD 15.45 USD
50 Day MA 1.57 USD
Shares Short Prior Month 241 049
200 Day MA 69.72 USD
Short Ratio 0.25
Shares Short 179 520
Short Percent 9.43 %